Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H11NO3 |
Molecular Weight | 229.2313 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=CC(O)=C(C=C1)C(=O)OC2=CC=CC=C2
InChI
InChIKey=DNVVZWSVACQWJE-UHFFFAOYSA-N
InChI=1S/C13H11NO3/c14-9-6-7-11(12(15)8-9)13(16)17-10-4-2-1-3-5-10/h1-8,15H,14H2
DescriptionCurator's Comment: description was created based on several sources, including:
https://pubchem.ncbi.nlm.nih.gov/compound/8609#section=Top
Curator's Comment: description was created based on several sources, including:
https://pubchem.ncbi.nlm.nih.gov/compound/8609#section=Top
Phenyl Aminosalicylate is the phenyl ester of para-aminosalicylic acid, reported to have less side effects than simple salts of para-aminosalicylic acid. It’s a second-line antituberculosis drug with a high incidence of hypersensitivity reactions and gastrointestinal upset.
Approval Year
Doses
Dose | Population | Adverse events |
---|---|---|
2.68 g 3 times / day multiple, oral Studied dose Dose: 2.68 g, 3 times / day Route: oral Route: multiple Dose: 2.68 g, 3 times / day Sources: Page: p.381 |
unhealthy n = 119 Health Status: unhealthy Condition: Tuberculosis Sex: M+F Population Size: 119 Sources: Page: p.381 |
Disc. AE: Nausea, Vomiting... AEs leading to discontinuation/dose reduction: Nausea (0.84%) Sources: Page: p.381Vomiting (0.84%) Gas (1.68%) Diarrhea (severe, 0.84%) Gastrointestinal discomfort (1.68%) Diarrhea (0.84%) Anorexia (0.84%) Nausea (severe, 0.84%) Vomiting (severe, 0.84%) |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Anorexia | 0.84% Disc. AE |
2.68 g 3 times / day multiple, oral Studied dose Dose: 2.68 g, 3 times / day Route: oral Route: multiple Dose: 2.68 g, 3 times / day Sources: Page: p.381 |
unhealthy n = 119 Health Status: unhealthy Condition: Tuberculosis Sex: M+F Population Size: 119 Sources: Page: p.381 |
Diarrhea | 0.84% Disc. AE |
2.68 g 3 times / day multiple, oral Studied dose Dose: 2.68 g, 3 times / day Route: oral Route: multiple Dose: 2.68 g, 3 times / day Sources: Page: p.381 |
unhealthy n = 119 Health Status: unhealthy Condition: Tuberculosis Sex: M+F Population Size: 119 Sources: Page: p.381 |
Nausea | 0.84% Disc. AE |
2.68 g 3 times / day multiple, oral Studied dose Dose: 2.68 g, 3 times / day Route: oral Route: multiple Dose: 2.68 g, 3 times / day Sources: Page: p.381 |
unhealthy n = 119 Health Status: unhealthy Condition: Tuberculosis Sex: M+F Population Size: 119 Sources: Page: p.381 |
Vomiting | 0.84% Disc. AE |
2.68 g 3 times / day multiple, oral Studied dose Dose: 2.68 g, 3 times / day Route: oral Route: multiple Dose: 2.68 g, 3 times / day Sources: Page: p.381 |
unhealthy n = 119 Health Status: unhealthy Condition: Tuberculosis Sex: M+F Population Size: 119 Sources: Page: p.381 |
Gas | 1.68% Disc. AE |
2.68 g 3 times / day multiple, oral Studied dose Dose: 2.68 g, 3 times / day Route: oral Route: multiple Dose: 2.68 g, 3 times / day Sources: Page: p.381 |
unhealthy n = 119 Health Status: unhealthy Condition: Tuberculosis Sex: M+F Population Size: 119 Sources: Page: p.381 |
Gastrointestinal discomfort | 1.68% Disc. AE |
2.68 g 3 times / day multiple, oral Studied dose Dose: 2.68 g, 3 times / day Route: oral Route: multiple Dose: 2.68 g, 3 times / day Sources: Page: p.381 |
unhealthy n = 119 Health Status: unhealthy Condition: Tuberculosis Sex: M+F Population Size: 119 Sources: Page: p.381 |
Diarrhea | severe, 0.84% Disc. AE |
2.68 g 3 times / day multiple, oral Studied dose Dose: 2.68 g, 3 times / day Route: oral Route: multiple Dose: 2.68 g, 3 times / day Sources: Page: p.381 |
unhealthy n = 119 Health Status: unhealthy Condition: Tuberculosis Sex: M+F Population Size: 119 Sources: Page: p.381 |
Nausea | severe, 0.84% Disc. AE |
2.68 g 3 times / day multiple, oral Studied dose Dose: 2.68 g, 3 times / day Route: oral Route: multiple Dose: 2.68 g, 3 times / day Sources: Page: p.381 |
unhealthy n = 119 Health Status: unhealthy Condition: Tuberculosis Sex: M+F Population Size: 119 Sources: Page: p.381 |
Vomiting | severe, 0.84% Disc. AE |
2.68 g 3 times / day multiple, oral Studied dose Dose: 2.68 g, 3 times / day Route: oral Route: multiple Dose: 2.68 g, 3 times / day Sources: Page: p.381 |
unhealthy n = 119 Health Status: unhealthy Condition: Tuberculosis Sex: M+F Population Size: 119 Sources: Page: p.381 |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C280
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID7021994
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | |||
|
DB06807
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | |||
|
SUB07538MIG
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | |||
|
40144
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | |||
|
2143
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | |||
|
CHEMBL1200868
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | |||
|
133-11-9
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | |||
|
C037254
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | |||
|
8609
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | |||
|
1844
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | |||
|
205-092-8
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | |||
|
100000081242
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | |||
|
52936SIP7V
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | |||
|
m8653
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
C66376
Created by
admin on Fri Dec 15 15:28:28 GMT 2023 , Edited by admin on Fri Dec 15 15:28:28 GMT 2023
|
PRIMARY |
ACTIVE MOIETY